Raw vector
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HCVSS and EPSS are reproduced from their sources (NVD, FIRST EPSS). EPSS, Forum of Incident Response and Security Teams (FIRST), epss.first.org. Risk Priority is our own derived reading, not an NVD score.
Summary
CVE-2023-33364 is a high-severity OS Command Injection (CWE-78) vulnerability in Supremainc Biostar 2. Its CVSS base score is 8.8 (High).
Operationally, exploitation aligns with the MITRE ATT&CK technique Exploitation for Privilege Escalation (T1068); ranked in the top 24% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.
OWASP Top 10 for Web (2025)
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2023-37527
Vulnerability Data
An OS Command injection vulnerability exists in Suprema BioStar 2 before V2.9.1, which allows authenticated users to execute arbitrary OS commands on the BioStar 2 server.
- CWE(s)
Related Threats
MITRE ATT&CK Enterprise Techniques
MITRE ATT&CK v20.0
CVEs Like This One
Affected Assets
Mitigating Controls
Control response
—
—
—
V1.2.5V1.2.8
Likely Mitigating Controls
Our mappings. Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Mitigating Controls (NIST CSF 2.0)
Our mappings, derived directly from the weakness types (CWEs) cited in the NVD entry via our CWE→CSF cross-walk — links open the control.
PR.PS-06's SDLC practices directly require secure coding and input handling that blocks command-injection defects, yet the single broad outcome leaves many specific neutralization vectors and verification gaps unaddressed.
Routine patching/maintenance can remediate known command-injection CVEs in dependencies (partial forward) but does nothing to stop developers from introducing improper neutralization in custom code (none reverse).
Mitigating Controls (ISO/IEC 27001:2022 Annex A)
Our mappings, derived directly from the weakness types (CWEs) cited in the NVD entry via our CWE→ISO cross-walk — links open the control.
Security testing and code review target insecure use of operating-system command interfaces, catching command-injection flaws introduced during development.
Training helps developers understand the risks of unsafe OS command construction and the need for input neutralization, but general awareness training is fallible and less directly applicable than dedicated secure coding practice (A.8.28, graded `partial` against XSS); most OS command injection instances arise from implementation mistakes that awareness alone does not prevent.
A.8.28 mandates secure coding practices (input validation, avoiding dangerous functions like system()/exec(), peer review, SAST during development) that prevent some OS command injection instances, but it is a practice-based control whose effect depends on developer skill and implementation rigor, leaving a fallible remainder that A.8.29 testing reaches more completely.
A.8.30 carries its effect through the secure-development practices (8.25–8.29) its contract requires of the supplier, so a faithfully implemented clause reduces ordinary software CWEs like OS command injection in delivered code the way those practices do, but the effect is mediated by the supplier's implementation and is not complete.
A.8.8's reach is DISCLOSURE — it finds OS command injection only where it has been published as a CVE in a third-party component, which is a minority of instances; most CWE-78 lives in first-party code that A.8.8's published-advisory and component-inventory programme does not read.